Your browser doesn't support javascript.
COVID-19 and Sodium-Glucose Cotransporter 2 Inhibitors: No Fear to Attempt?
Papachristou, Stella; Penlioglou, Theano; Stoian, Anca Pantea; Papanas, Nikolaos.
  • Papachristou S; Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, Alexandroupolis, Greece.
  • Penlioglou T; Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, Alexandroupolis, Greece.
  • Stoian AP; Diabetes, Nutrition and Metabolic Diseases Department, "Carol Davila" University of Medicine, Bucharest, Romania.
  • Papanas N; Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, Alexandroupolis, Greece.
Exp Clin Endocrinol Diabetes ; 130(3): 198-199, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-759628
ABSTRACT
Novel coronavirus infectious disease (COVID-19) has been recognised as a pandemic by the World Health Organization (WHO) 1. Mortality and morbidity are higher in elderly individuals and those with comorbidities, such as diabetes mellitus (DM), obesity, hypertension, respiratory tract diseases, coronary heart disease or cancer 1. Indeed, two thirds of individuals who died from COVID-19 had DM in Italy 2.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Communicable Diseases / Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors / COVID-19 Type of study: Observational study Limits: Aged / Humans Language: English Journal: Exp Clin Endocrinol Diabetes Journal subject: Endocrinology Year: 2022 Document Type: Article Affiliation country: A-1235-5617

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Communicable Diseases / Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors / COVID-19 Type of study: Observational study Limits: Aged / Humans Language: English Journal: Exp Clin Endocrinol Diabetes Journal subject: Endocrinology Year: 2022 Document Type: Article Affiliation country: A-1235-5617